These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15683434)

  • 1. Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study.
    Imai Y; Kubota Y; Yamamoto S; Tsuji K; Shimatani M; Shibatani N; Takamido S; Matsushita M; Okazaki K
    J Gastroenterol Hepatol; 2005 Feb; 20(2):287-93. PubMed ID: 15683434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
    Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines.
    Kamiyama T; Une Y; Uchino J; Hamada J
    Int J Oncol; 1998 Mar; 12(3):655-9. PubMed ID: 9472107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
    Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
    Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
    Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
    Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticancer effect of balloon laserthermia on human cholangiocellular carcinoma].
    Koito K
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):731-41. PubMed ID: 7959590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
    Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
    Matsumoto-Taniura N; Matsumoto K; Nakamura T
    Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor regulates transforming growth factor alpha in HepG2 hepatic cells.
    Shiota G; Nakamura T; Schmidt EV
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1099-104. PubMed ID: 8179588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
    Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
    Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2].
    Xiao ZY; Wang YD; Chen XP
    Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.
    Wang P; Nishitani MA; Tanimoto S; Kishimoto T; Fukumori T; Takahashi M; Kanayama HO
    Urology; 2007 Apr; 69(4):780-4. PubMed ID: 17445681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
    Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro.
    Xia D; Yan LN; Xie JG; Tong Y; Yan ML; Wang XP; Zhang MM; Zhao LY
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):409-15. PubMed ID: 16911941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.